发明名称 |
CONTROLLED RELEASE NUCLEATED TABLET |
摘要 |
Disclosed is a controlled release nucleated tablet which is composed of an inner nucleus and an outer layer that covers the inner nucleus and is capable of maintaining the level of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5- thiazolecarboxylic acid in the blood to a certain value or higher for a long period of time. The controlled release nucleated tablet is characterized in that the inner nucleus contains 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5- thiazolecarboxylic acid and the outer layer contains 2-(3-cyano- 4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid and a gel-forming water-soluble polymer that is in an amount of 16 (w/w)% or more relative to the weight of the outer layer. |
申请公布号 |
EP2594269(A4) |
申请公布日期 |
2013.12.04 |
申请号 |
EP20110795774 |
申请日期 |
2011.06.15 |
申请人 |
TEIJIN PHARMA LIMITED |
发明人 |
FUJINAGA, KENTARO;MARUO, SUSUMU;NAKAMURA, HIDEAKI;SUNAGAWA, KENJI;MOCHIZUKI, TSUTOMU;KAGEYAMA, MICHIHARU |
分类号 |
A61K31/426;A61K9/24;A61K9/26;A61K9/28;A61K47/38 |
主分类号 |
A61K31/426 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|